| Patent(s) and the Corresponding Patented Drug(s) |
Top |
| World Intellectual Property Organization (WIPO) |
| Patent ID |
WO2014089450 |
| Title |
Specific Inhibitors of Cdk3. |
| Abstract |
The invention provides new compounds and methods for inhibiting Cyclin-Dependent Kinase 3 (CDK3), and new methods for identifying such compounds. |
| Applicant(s) |
Senex Biotechnology, Inc |
| Representative Drug(s) |
D0FQ6V |
Drug Info
|
IC50 = 470 nM |
[1] |
| Patent ID |
WO2010075542 |
| Title |
Cdk Inhibitors. |
| Abstract |
The present invention relates to CDK inhibitors and their use in the treatment of cell proliferative diseases such as cancer. |
| Applicant(s) |
Curis, Inc |
| Representative Drug(s) |
D0M5DX |
Drug Info
|
IC50 < 100 nM |
[1] |
| Patent ID |
WO2009036016 |
| Title |
Cdk Inhibitors Containing A Zinc Binding Moiety. |
| Abstract |
The present invention relates to CDK inhibitors and their use in the treatment of cell proliferative diseases such as cancer. The compounds of the invention may further act as HDAC inhibitors. |
| Applicant(s) |
Curis, Inc |
| Representative Drug(s) |
D0M5DX |
Drug Info
|
IC50 < 100 nM |
[1] |
| Patent ID |
WO2013049279 |
| Title |
Nitrogen Mustard Derivatives. |
| Abstract |
The disclosure includes compounds of Formula (1): wherein X1, X2, Q, Z, R1, and R2 are defined herein. Also disclosed is a method for treating a neoplastic disease or an immune disease with these compounds. |
| Applicant(s) |
Euro-Celtique Sa |
| Representative Drug(s) |
D0LK4L |
Drug Info
|
N.A. |
[1] |
